LIST OF ABBREVIATIONS

Size: px
Start display at page:

Download "LIST OF ABBREVIATIONS"

Transcription

1 LIST OF ABBREVIATIONS AC ACGR AIOCD ANDA API APL AR ASP BDMA BSL BSP CAGR C-D CF CIL CIS CMA CMIE CMO CPI CPWD CR CR CRAMS CRCA CRISIL CRO CRS CSP Average Cost Annual Compound Growth Rate All India Organisation of Chemists & Druggists Abbreviated New Drug Applications Active Pharmaceutical Ingredients Aurobindo Pharma Ltd. Average Revenue Alloy Steels Plant Bulk Drug Manufacturers Association (India) Bokaro Steel Plant Bhilai Steel Plant Compound Annual Growth Rate Competition Commission of India Corporate Catalyst India Competition Commission of India Cobb- Douglas Cash flow Coal India Ltd. Commonwealth of Independent States Cement Manufacturers Association Centre for Monitoring the Indian Economy Contract Manufacturing Consumer price Index Central Public Works Department Current Ratio Cold Rolled The Indian Contract Research and Manufacturing Services Cold Tolled Close Annealed Coils Credit Rating and Information Services of India Ltd. Contract Research Organisation Constant Returns to Scale Compact Strip Process v

2 Cu M CVD CVS CVS CY D DC DCP DDDS DER DIPP DIV DMF DPCO DRI DSP EAF EBIT EDQM EMEA EV FB FDA FDI FE FI FII FIPB FIPB FS FTF GC GDP GP GVC Cubic meters Special Countervaling Duty CVS Pharmacy Cardiovascular Calendar Year Value of Debt Domestic Corporations DI- Calcium Phosphate Drug Discovery & Development Solutions Debt to Equity Ratio Department of Industrial Policy & Promotion Dividend Drug Master Files Drugs Price Control Orders Direct Reduced Iron Durgapur Steel Plant Electrical Arc Furnance Earnings before Internet and Taxes European Directorate of Quality Medicine European Medicines Agency Enterprise Value Foreign Borrowing Food & Drug Administration Foreign Direct Investment Foreign Equity Federation of Indian Chambers of Commerce and Industry Foreign Institutional Investor Foreign Investment Promotion Board Foreign Investment Promotion Board Financial Structure First to File Galvanized Coil Gross Domestic product Galvanized Steel Gross Calorific Value vi

3 HBI HR ICHGCP ICRA IF IMP ISP IT JSPL JVCL K K(KCal/kg) K(Wh/t) K/L K d K o K s Ku LRE LRK LRO LRW M&A M.P. MCL MHRA MNC MR MRP MRS MT MTPA NCA NCE Hot Briquetted Iron Hot Rolled Steel International Conference on Harmonisation Good Clinical Practice Investment Information and Credit Rating Agency of India Ltd. Induction furnance Imports IISCO Steel Plant Information Technology Jindal Steel & Power Ltd. Jindal Vijay Nagar Steel Ltd. Capital Kilocaloric/Kilogram Kilowatt per Hour Technology Cost of Debt Overall Capitalization Rate Cost of Equity Capital Cost of Unlevered Firm Log of Teal Energy Log of Teal Capital Log of Teal Output Log of Teal Wages Mergers & Acquisitions Marginal Product Madras Cements Ltd. UK Medicines and Healthcare Products Regulatory Agency Multinationals Corporations Marginal Revenue Marginal Revenue Product Marginal Rate of Substitution Million Tonnes Million Tonnes per Annum Net Cash Accruals New Chemical Entity vii

4 NDDS NDTS NFA NI NICS NIH NOI NPPA NSP OPC OTC P/E PBFS PPC PPES PPPs PSE PWD Q/L R&D RBI RINL RMC ROE ROE ROW ROY RSP S SAIL SAL SCL SDF SFP SPCC Novel Drug Delivery Systems Non Debt Tax Shields Net Fixed Assets Net Income Newly Industrialized Country National Institutes of Health Net Operating Income National Pharmaceutical Pricing Authority National Steel Policy Ordinary Portland Cement Over the Counter Price Earnings Ratio Portland Blast Furnance Slag Portland Pozzolona Cement Proprietary Products & Inclusive Synthesis Business Private Partnership Projects Public Sector Enterprises Public Works Department Labour Productivity Research and Development Reserve Bank of India Rashtriya Ispat Nigam Ltd. Ready Mix Concrete Return on Equity Return on Equity Rest of World Royalties, Technical Know-how Fees, etc. Rourkela Steel Plant Value of Equity Steel Authority of India Ltd. Sales Shree Cement Limited Steel Development fund Single Factor Productivity Steel Promotion Coordination Committee viii

5 SPSS SSP T T TC T c TCA TFE TFP TPL TRIPS T s TSL U.S. UCL UHV UK USA V f WPI Y-O-Y Statistical Package for the Social Sciences Salem Steel Plant Tax Time Total Cost Corporate Tax Transaction Costs Approach Total Forex Comings Total Factor Productivity Torrent Pharmaceutical Ltd. Trade Related Aspects of Intellectual Property Rights Personal Tax Tata Services Ltd. United States Ultra Tech Cement Ltd. Useful Heat Value United Kingdom United States of America Value of Firm Wholesale Price Index Year Over Year ix

Chapter-4 Research Methodology

Chapter-4 Research Methodology Research Methodology CHAPTER-4 RESEARCH METHODOLOGY 4.0. INTRODUCTION In the previous chapter we have discussed the conceptual framework for our study. The research methodology is divided into five parts

More information

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%) BUY CMP 86.30 Target Price 104.00 STEEL AUTHORITY OF INDIA LTD Result Update (PARENT BASIS): Q1 FY15 SEPTEMBER 3 rd,2014 ISIN: INE114A01011 Index Details Stock Data Sector Iron & Steel BSE Code 500113

More information

Steel In The News. A compilation of leading news items on Indian steel industry as reported in major national dailies. Raw Materials 2.

Steel In The News. A compilation of leading news items on Indian steel industry as reported in major national dailies. Raw Materials 2. Steel In The News A compilation of leading news items on Indian steel industry as reported in major national dailies CONTENTS Page Raw Materials 2 Company News 2 Projects 3 Financials 4 Policy 4 Industry

More information

India Growth Story. Steel Market Asia Conference Ashok Bhardwaj. 19 th -20 th November Intercontinental Grand Stanford - Hong Kong

India Growth Story. Steel Market Asia Conference Ashok Bhardwaj. 19 th -20 th November Intercontinental Grand Stanford - Hong Kong India Growth Story Steel Market Asia Conference 2012 19 th -20 th November - 2012 Intercontinental Grand Stanford - Hong Kong Ashok Bhardwaj (Director - Marketing) JSW Steel Limited India Urbanization

More information

O.P. Jindal Group and JSW Group Overview

O.P. Jindal Group and JSW Group Overview July 01, 20091 Group Overview 2 O.P. Jindal Group and JSW Group Overview P R Jindal Sajjan Jindal Ratan Jindal Naveen Jindal Jindal Saw Jindal Stainless Jindal Steel & Power Ltd. Power Steel Infrastructure

More information

JSW reports flat sales in Q3 FY

JSW reports flat sales in Q3 FY Press Release 28.01.2009 JSW reports flat sales in Q3 FY 2008-09 JSW reported flat sales in the 3rd quarter when the world steel demand and prices fell significantly mainly due to change in the product

More information

International Journal of Multidisciplinary Research Review, Vol.1, Issue-35, January Page - 80

International Journal of Multidisciplinary Research Review, Vol.1, Issue-35, January Page - 80 SHARE PRICE MOVEMENT OF STEEL COMPANIES LISTED IN BOMBAY STOCK EXCHANGE (BSE) Sujetthra.A* Dharani.A** *Assistant Professor, Department of Commerce, Sri Krishna Adithya College of Arts and Science, Coimbatore.

More information

National Fittings Limited

National Fittings Limited National Fittings Limited Date: 13 th January, 2016 Stock Performance Details Shareholding Details September 2015 Current Price : ` 100.5^ Face Value : ` 10 per share 52 wk High / Low : ` 107.9 / 57.0

More information

Steel In The News. A compilation of leading news items on Indian steel industry as reported in major national dailies. Company News 3.

Steel In The News. A compilation of leading news items on Indian steel industry as reported in major national dailies. Company News 3. Steel In The News A compilation of leading news items on Indian steel industry as reported in major national dailies CONTENTS Page Highlight of the Week 2 Raw Material 2 Company News 3 Policy 4 Global

More information

Bird s Eye View of Indian Pharma

Bird s Eye View of Indian Pharma Bird s Eye View of Indian Pharma Classification of Pharma Industry Pharma industry Formulations Active Pharmaceuticals Ingredients Branded Generics Bulk drugs Pfizer Abbott GSK BMS Teva Mylan Dr Reddy

More information

Agenda. Overview. Key Highlights. Performance Review. Projects Update and Guidance. Steel Scenario

Agenda. Overview. Key Highlights. Performance Review. Projects Update and Guidance. Steel Scenario May 2011 Agenda Overview Key Highlights Performance Review Projects Update and Guidance Steel Scenario 2 JSW Group Overview A USD 7 billion group with diversified interests in Steel, Energy, Minerals and

More information

IFGL Refractories Limited (Formerly IFGL Exports Limited) Investor Presentation February 2018

IFGL Refractories Limited (Formerly IFGL Exports Limited) Investor Presentation February 2018 IFGL Refractories Limited (Formerly IFGL Exports Limited) Investor Presentation February 2018 Safe Harbor This presentation and the accompanying slides (the Presentation ), has been prepared by IFGL Refractories

More information

Aurobindo Pharma BUY. Performance Highlights CMP. `109 Target Price `156. 1QFY2013 Result Update Pharmaceutical. Investment Period 12 months

Aurobindo Pharma BUY. Performance Highlights CMP. `109 Target Price `156. 1QFY2013 Result Update Pharmaceutical. Investment Period 12 months 1QFY2013 Result Update Pharmaceutical August 8, 2012 Aurobindo Pharma Performance Highlights Y/E march (` cr) 1QFY2013 4QFY2012 % chg (qoq) 1QFY2012 % chg (yoy) Net sales 1197 1171 2.3 1065 12.4 Other

More information

Valuation & Recommendation. planning to increase its capacity from the current 6.8mtpa to

Valuation & Recommendation. planning to increase its capacity from the current 6.8mtpa to Recommendation SUBSCRIBE Investment rationale: Issue Price Rs. 594 610 Expansion Projects to enhance Capacity: Tata Steel is planning to increase its capacity from the current 6.8mtpa to Bidding Date 19

More information

GUFIC MANAGEMENT DISCUSSION AND ANALYSIS

GUFIC MANAGEMENT DISCUSSION AND ANALYSIS GUFIC BIOSCIENCES LIMITED MANAGEMENT DISCUSSION AND ANALYSIS Indian Pharma Industry an overview The Indian Pharmaceutical industry has been witnessing phenomenal growth in recent years, driven by rising

More information

Aurobindo Pharma Limited Presentation to Investors

Aurobindo Pharma Limited Presentation to Investors Aurobindo Pharma Limited Presentation to Investors February 2013 Forward looking statement This presentation contains statements that constitute forward looking statements including and without limitation,

More information

Canara Bank Securities Ltd

Canara Bank Securities Ltd A WHOLLY OWNED SUBSIDIARY OF CANARA BANK Ajanta Pharma (IC) LTP : 1481 Date :26 th Dec 2017 Stock Info Sector Market Target 1728 Holding Period Pharmaceuticals & Drugs Domestic & International 9-11 months

More information

Peer Groups CMP Market Cap EPS P/E (x) P/BV(x) Dividend Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

Peer Groups CMP Market Cap EPS P/E (x) P/BV(x) Dividend Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%) BUY CMP 16.50 Target Price 18.00 ANKIT METAL & POWER LIMITED Result Update: Q3 FY13 MAR 8 th, 2013 ISIN: INE106I01010 Stock Data Sector Iron & Steel BSE Code 532870 Face Value 10.00 52wk. High / Low (Rs.)

More information

Madras Cements Ltd 9 th October, 2012 BUY

Madras Cements Ltd 9 th October, 2012 BUY Company Report BROKING DEPOSITORY DISTRIBUTION FINANCIAL ADVISORY Madras Cements Ltd 9 th October, 2012 BUY CMP Target Price Rs.186.35 Rs.240.00 Madras Cements Ltd is the flagship company of the Ramco

More information

WORKING CAPITAL MANAGEMENT IN SELECTED PUBLIC SECTOR COMPANIES: A COMPARATIVE STUDY IN WEST BENGAL Bijoy Gupta 1

WORKING CAPITAL MANAGEMENT IN SELECTED PUBLIC SECTOR COMPANIES: A COMPARATIVE STUDY IN WEST BENGAL Bijoy Gupta 1 WORKING CAPITAL MANAGEMENT IN SELECTED PUBLIC SECTOR COMPANIES: A COMPARATIVE STUDY IN WEST BENGAL Bijoy Gupta 1 Prof Kartick Chandra Paul 2 Abstract: Working capital is life blood of any business irrespective

More information

Monnet Ispat SYNOPSIS. Target Price: Rs Date: Sep 30 th 2011 BUY

Monnet Ispat SYNOPSIS. Target Price: Rs Date: Sep 30 th 2011 BUY Monnet Ispat Ltd Result Update: Q1 FY 12 C.M.P: Rs.490.00 Target Price: Rs.559.00 Date: Sep 30 th 2011 BUY Stock Data: Sector: Steel Face Value Rs. 10.00 52 wk. High/Low (Rs.) 682.00/449.00 Volume (2 wk.

More information

Ratio Analysis of Tata Steel and Jindal Steel (A Comparative Study)

Ratio Analysis of Tata Steel and Jindal Steel (A Comparative Study) Analysis of Tata Steel and Jindal Steel (A Comparative Study) Amandeep Assistant Professor,Baba Farid College, Bathinda ABSTRACT The analysis forms an essential part of the financial statements which is

More information

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%) BUY CMP 538.15 Target Price 592.00 TORRENT PHARMACEUTICALS LTD Result Update: Q3 FY14 JANUARY 25 th 2014 ISIN: INE685A01028 Index Details Stock Data Sector Pharmaceuticals BSE Code 500420 Face Value 5.00

More information

Growth of Manufacturing Sector in Post-Reforms India Some Disquieting Features

Growth of Manufacturing Sector in Post-Reforms India Some Disquieting Features Growth of Manufacturing Sector in Post-Reforms India Some Disquieting Features Sudip Chaudhuri INTRODUCTION Extensive economic reforms have been carried out in India since 1991. In industry and trade,

More information

Chapter 7. Summary Findings and Suggestions Chapter 1 Conceptual Framework of Financial Efficiency.

Chapter 7. Summary Findings and Suggestions Chapter 1 Conceptual Framework of Financial Efficiency. Chapter 7 Summary Findings and Suggestions 7.1. Chapter 1 Conceptual Framework of Financial Efficiency. 7.2. Chapter 2 An Overview of Indian Steel Industry. 7.3. Chapter 3 Literature Review. 7.4. Chapter

More information

Ranbaxy Q3 FY 2015 Sales Rs.25,876 Mn. YTD Dec 14 Sales Rs.81,778 Mn

Ranbaxy Q3 FY 2015 Sales Rs.25,876 Mn. YTD Dec 14 Sales Rs.81,778 Mn For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please

More information

Steel Authority of India Ltd Steel Products HOLD RETAIL EQUITY RESEARCH. CMP Rs. 62 TARGET Rs. 65 RETURN 6% 24 th October 2017 COMPANY UPDATE

Steel Authority of India Ltd Steel Products HOLD RETAIL EQUITY RESEARCH. CMP Rs. 62 TARGET Rs. 65 RETURN 6% 24 th October 2017 COMPANY UPDATE COMPANY UPDATE RETAIL EQUITY RESEARCH Steel Authority of India Ltd Steel Products BSE CODE: 500410 NSE CODE: SAIL Bloomberg CODE: SAIL:IN SENSEX: 32,607 HOLD Rating as per Largecap 12months investment

More information

To Measure the Liquidity Of Selected Private Sector Pharmaceutical Companies in India

To Measure the Liquidity Of Selected Private Sector Pharmaceutical Companies in India To Measure the Liquidity Of Selected Private Sector Pharmaceutical Companies in India Dr.K.Ayappan Assistant Professor, Government Arts College (Autonomous),Kumbakonam Abstract: The Indian pharmaceuticals

More information

Steel Authority of India

Steel Authority of India BSE SENSEX S&P CNX 16,439 4,990 4QFY12 Results Update Sector: Metals Steel Authority of India CMP: INR93 TP: INR99 Sell Bloomberg SAIL IN Equity Shares (m) 4,130.4 52-Week Range (INR) 151/73 1,6,12 Rel.

More information

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update Aug-15 Nov-15 Feb-16 May-16 Aug-16 Nov-16 Feb-17 May-17 Aug-17 Nov-17 Feb-18 May-18 Aug-18 1QFY2019 Result Update Steel & Power August 14, 2018 Jindal Steel & Power Performance Update INR Cr. Q1FY19 Q1FY18

More information

IFGL Refractories Limited (Formerly IFGL Exports Limited) Investor Presentation May 2018

IFGL Refractories Limited (Formerly IFGL Exports Limited) Investor Presentation May 2018 IFGL Refractories Limited (Formerly IFGL Exports Limited) Investor Presentation May 2018 Safe Harbor This presentation and the accompanying slides (the Presentation ), has been prepared by IFGL Refractories

More information

A STUDY ON FOREIGN DIRECT INVESTMENT INFLOWS INTO INDIA

A STUDY ON FOREIGN DIRECT INVESTMENT INFLOWS INTO INDIA A STUDY ON FOREIGN DIRECT INVESTMENT INFLOWS INTO INDIA A thesis submitted to BHARATHIDASAN UNIVERSITY for the award of the degree of DOCTOR OF PHILOSOPHY IN ECONOMICS By G. PANNEERSELVAM [Reg. No. 014973/Ph.D.2/Economics/Part-Time/July

More information

Views on the Generics Market

Views on the Generics Market Views on the Generics Market Dr Brian Tempest Chief Mentor & Executive Vice Chairman of the Board Ranbaxy Laboratories, Delhi, India EGA Conference Istanbul, Turkey 15 th June 2007 Safe Harbor Except for

More information

Granules India Ltd. 21 st July, 2012

Granules India Ltd. 21 st July, 2012 Company Report BROKING DEPOSITORY DISTRIBUTION FINANCIAL ADVISORY Granules India Ltd. 21 st July, 2012 CMP Target Price Rs.149.30 Rs.200.00 Granules India is among the leading global manufacturer of highvolume

More information

JUBILANT LIFE SCIENCES Q2 & H1 FY19 RESULTS

JUBILANT LIFE SCIENCES Q2 & H1 FY19 RESULTS PRESS RELEASE Noida, Monday, Oct 22, 2018 Jubilant Life Sciences Ltd. 1A, Sector 16A, Noida 201301, India Tel.: +91 120 4361000 http://www.jubl.com JUBILANT LIFE SCIENCES Q2 & H1 FY19 RESULTS JUBILANT

More information

Dr Reddy s Laboratories

Dr Reddy s Laboratories 1QFY2017 Result Update Pharmaceutical July 29, 2016 Dr Reddy s Laboratories Performance Highlights Y/E March (` cr) 1QFY2017 4QFY2016 % chg (qoq) 1QFY2016 % chg (yoy) Net sales 3,235 3,756 (13.9) 3,758

More information

IFGL Refractories Limited (Formerly IFGL Exports Limited) Investor Presentation August 2018

IFGL Refractories Limited (Formerly IFGL Exports Limited) Investor Presentation August 2018 IFGL Refractories Limited (Formerly IFGL Exports Limited) Investor Presentation August 2018 Safe Harbor This presentation and the accompanying slides (the Presentation ), has been prepared by IFGL Refractories

More information

Aurobindo Pharma Limited. Presentation to Investors

Aurobindo Pharma Limited. Presentation to Investors Aurobindo Pharma Limited Presentation to Investors November 2013 Forward looking statement This presentation contains statements that constitute forward looking statements including and without limitation,

More information

Aurobindo Pharma ACCUMULATE. Performance Highlights. `780 Target Price CMP `855. 2QFY2019 Result Update Pharmaceutical. Investment Period 12 months

Aurobindo Pharma ACCUMULATE. Performance Highlights. `780 Target Price CMP `855. 2QFY2019 Result Update Pharmaceutical. Investment Period 12 months Nov-15 Mar-16 Jul-16 Nov-16 Mar-17 Jul-17 Nov-17 Mar-18 Jul-18 Nov-18 2QFY2019 Result Update Pharmaceutical November 17, 2018 Aurobindo Pharma Performance Highlights Y/E march (` cr) 2QFY19 1QFY19 % chg

More information

Electrotherm (India) Ltd.

Electrotherm (India) Ltd. Electrotherm (India) Ltd. Investor Presentation Q1 June 10 (FY 2010 2011) A world class engineering major, catering to manufacturing and metallurgical sector 2010 All rights reserved. Electrotherm (India)

More information

STEEL For updated information, please visit December 2018

STEEL For updated information, please visit   December 2018 STEEL December 2018 Table of Content Executive Summary.....3 Advantage India......4 Market Overview....6 Recent Trends and Strategies...15 Growth Drivers...19 Opportunities..... 25 Key Industry Associations...28

More information

PRESS RELEASE FINANCIAL RESULTS FOR Q4 & FULL YEAR 14-15

PRESS RELEASE FINANCIAL RESULTS FOR Q4 & FULL YEAR 14-15 PRESS RELEASE FINANCIAL RESULTS FOR Q4 & FULL YEAR 14-15 NAVIGATING THROUGH CHALLENGING TIMES JSPL Standalone Performance: Crude Steel Production: 0.81 million tonnes Steel Sales: 0.79 million tonnes Gross

More information

Rajinder Miglani CMD Uttam Galva Steels Ltd

Rajinder Miglani CMD Uttam Galva Steels Ltd Mittal enters India Becomes co-promoter of Uttam Galva Steels Ltd. - Steelworld Research Team Rajinder Miglani CMD Uttam Galva Steels Ltd Lakshmi N. Mittal Chairman and CEO ArcelorMittal n a deal that

More information

ACETO Corporation. June 8, 2016

ACETO Corporation. June 8, 2016 NASDAQ:ACET ACETO Corporation Jefferies Healthcare Conference June 8, 2016 Sourcing & Supplying Quality Products Worldwide Disclosure This presentation contains forward-looking statements, as defined by

More information

PRESS RELEASE FINANCIAL RESULTS FOR FIRST QUARTER - FY16. Enhanced capacities Pushing up Production & Sales Volumes

PRESS RELEASE FINANCIAL RESULTS FOR FIRST QUARTER - FY16. Enhanced capacities Pushing up Production & Sales Volumes PRESS RELEASE FINANCIAL RESULTS FOR FIRST QUARTER - FY16 Enhanced capacities Pushing up Production & Sales Volumes JSPL Standalone 1QFY16 Performance : Crude Steel Production: 0.86 million tonnes Steel

More information

Motilal Oswal MidCap 100 ETF

Motilal Oswal MidCap 100 ETF Motilal Oswal MidCap 100 ETF Product labeling This product is suitable for investors who are seeking* Return that corresponds generally to the performance of the NIFTY Midcap 100 index, subject to tracking

More information

Steel In The News. A compilation of leading news items on Indian steel industry as reported in major national dailies. Highlight of the Week 2

Steel In The News. A compilation of leading news items on Indian steel industry as reported in major national dailies. Highlight of the Week 2 Steel In The News A compilation of leading news items on Indian steel industry as reported in major national dailies CONTENTS Page Highlight of the Week 2 Company News 2 Projects 3 Policy 4 Steel Performance

More information

Financial Results Analysis Quarter & Half Year Ended September 30, 2011

Financial Results Analysis Quarter & Half Year Ended September 30, 2011 Financial Results Analysis Quarter & Half Year Ended September 30, 2011 Disclaimer 1 Statements in this document relating to future status, events, or circumstances, including but not limited to statements

More information

DIL Ltd. Pharmaceuticals. Company Overview. Company Fundamentals. CMP Rs

DIL Ltd. Pharmaceuticals. Company Overview. Company Fundamentals. CMP Rs Pharmaceuticals September 26, 2012 CMP Rs. 700.4 BSE Code 506414 BSE ID DIL High/Low 1Y (Rs.) 748.2 / 373.9 Average Volume (3M) 579.8 Market Cap (Rs. Cr.) 161.1 Shareholding % Jun-12 Mar-12 Promoters 63.20

More information

Press Presentation Q1 FY19

Press Presentation Q1 FY19 1 July 26, 2018 Q1 FY19 Press Meet Press Presentation Q1 FY19 Safe Harbor Statement This presentation contains forward-looking statements and information that involve risks, uncertainties and assumptions.

More information

Dr. Reddy s Laboratories

Dr. Reddy s Laboratories Mar-12 Aug-12 Jan-13 Jun-13 Nov-13 Apr-14 Sep-14 Feb-15 Jul-15 Dec-15 May-16 Oct-16 Mar-17 Aug-17 2QFY2018 Result Update Pharmaceutical November 24, 2017 Dr. Reddy s Laboratories Performance Highlights

More information

JUBILANT LIFE SCIENCES Q4/FY2017 RESULTS

JUBILANT LIFE SCIENCES Q4/FY2017 RESULTS PRESS RELEASE Noida, Tuesday, May 23, 2017 Jubilant Life Sciences Ltd. 1A, Sector 16A, Noida 201301, India Tel.: +91 120 4361000 http://www.jubl.com JUBILANT LIFE SCIENCES Q4/FY2017 RESULTS JUBILANT REPORTS

More information

Investor Presentation January 2016

Investor Presentation January 2016 Investor Presentation Forward-Looking Statements This presentation contains certain forward-looking statements and information relating to S.A. and its subsidiaries (collectively, ) that are based on the

More information

INVESTOR PRESENTATION. November 2015

INVESTOR PRESENTATION. November 2015 INVESTOR PRESENTATION November 2015 Disclaimer This presentation contains statements that constitute forward looking statements including and without limitation, statements relating to the implementation

More information

Q3 FY09 Results Update

Q3 FY09 Results Update Q3 FY09 Results Update January 20, 2009 1 Safe Harbor Statement This presentation contains forward-looking statements and information that involve risks, uncertainties and assumptions. Forward-looking

More information

MACRO-ECONOMICS REGULATORY INFRASTRUCTURE PHARMA INDUSTRY

MACRO-ECONOMICS REGULATORY INFRASTRUCTURE PHARMA INDUSTRY MACRO-ECONOMICS Economic growth are potentially good GDP per capita above $ 3.000 Government health budget increases to 5% Middle class category is projected into 150 Mn in 2014, average life expectancy

More information

Trends.. February 2019

Trends.. February 2019 1 Trends.. February 2019 The Interim Budget focused on social infrastructure, easing of tax burden and governance issues aimed at inclusive growth. Higher disposable incomes, Direct Benefit Transfer to

More information

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period - 4QCY2012 Result Update Cement February 11, 2013 ACC Performance Highlights Quarterly results (Standalone) Y/E Dec. (` cr) 4QCY2012 3QCY2012 % chg qoq 4QCY2011 % chg yoy Net sales 3,099 2,445 26.8 2,503

More information

A Study on Receivables Management in Select Companies of Indian Steel Industry

A Study on Receivables Management in Select Companies of Indian Steel Industry ISSN 2278 0211 (Online) A Study on Receivables Management in Select Companies of Indian Steel Industry Dr. Pinku Paul Assistant Professor, Department of Finance, Management Development Institute Murshidabad,

More information

Everest Industries Ltd Result Update: Q4 FY 12

Everest Industries Ltd Result Update: Q4 FY 12 Everest Industries Ltd Result Update: Q4 FY 12 C.M.P: Rs. 196.00 Target Price: Rs. 220.00 Date: June 28 th 2012 BUY Stock Data: Sector: Cement Face Value Rs. 10.00 52 wk. High/Low (Rs.) 206.45/102.50 Volume

More information

Syneos Health, Inc. Investment Research Presentation

Syneos Health, Inc. Investment Research Presentation Syneos Health, Inc. Investment Research Presentation NasdaqGS: SYNH Month Sector: Day, Healthcare 20XX Senior Analyst: Jose Grullon Junior Analysts: Garbis Chekerdjian, Ignacio Fimbres Spring 2018 1 Valuation

More information

F I R S T C A L L BUY R E S E A R C H JINDAL STEEL & POWER LTD

F I R S T C A L L BUY R E S E A R C H JINDAL STEEL & POWER LTD C.M.P: Rs.686.60 Stock Data Sector Face Value(Rs) JINDAL STEEL & POWER LTD 1 Year Comparative Graph Jindal Steel & Power Ltd Steel Rs.1.00 52 wk. High/Low (Rs.) Rs.755.25/550.00 Volume (2 wk. Avg.) 61000

More information

Steel In The News. A compilation of leading news items on Indian steel industry as reported in major national dailies. Highlight of the Week 2

Steel In The News. A compilation of leading news items on Indian steel industry as reported in major national dailies. Highlight of the Week 2 Steel In The News A compilation of leading news items on Indian steel industry as reported in major national dailies CONTENTS Page Highlight of the Week 2 Raw Material 2 Company News Projects Policy Steel

More information

Press Presentation Q4 18 & FY18

Press Presentation Q4 18 & FY18 1 May 22, 2018 Q4 FY18 Press Meet Press Presentation Q4 18 & FY18 Safe Harbor Statement This presentation contains forward-looking statements and information that involve risks, uncertainties and assumptions.

More information

JSW STEEL LTD. Result Update: Q1 FY 12. C.M.P : Rs Target Price : Rs Date : 03 rd Sep 2011 BUY. Share Holding Pattern

JSW STEEL LTD. Result Update: Q1 FY 12. C.M.P : Rs Target Price : Rs Date : 03 rd Sep 2011 BUY. Share Holding Pattern JSW STEEL LTD Result Update: Q1 FY 12 C.M.P : Rs.720.00 Target Price : Rs.814.00 Date : 03 rd Sep 2011 BUY Stock Data: Sector: Steel Face Value Rs. Rs.10.00 52 wk. High/Low (Rs.) 1400.00/594.65 Volume

More information

Aurobindo Pharma BUY. Performance Highlights. `708 Target Price CMP `823. 2QFY2018 Result Update Pharmaceutical. Investment Period 12 months

Aurobindo Pharma BUY. Performance Highlights. `708 Target Price CMP `823. 2QFY2018 Result Update Pharmaceutical. Investment Period 12 months Aug-14 Nov-14 Feb-15 May-15 Aug-15 Nov-15 Feb-16 May-16 Aug-16 Nov-16 Feb-17 May-17 Aug-17 Nov-17 2QFY2018 Result Update Pharmaceutical November 20, 2017 Aurobindo Pharma Performance Highlights Y/E march

More information

Product Labeling. Investment in equity securities of NIFTY Midcap 100 index

Product Labeling. Investment in equity securities of NIFTY Midcap 100 index Title slide Product Labeling This product is suitable for investors who are seeking* Return that corresponds generally to the performance of the NIFTY Midcap 100 index, subject to tracking error. Investment

More information

Indian Pharmaceutical Formulations Industry Report,

Indian Pharmaceutical Formulations Industry Report, Indian Pharmaceutical Formulations Industry Report, 2008-2009 India plays an important role in the global pharmaceutical market. In 2005, 2/5 DMFs to FDA were submitted by India. Currently, there are more

More information

Growth and Profitability of Selected Cement Industries in India

Growth and Profitability of Selected Cement Industries in India Volume 5, Issue 1 June 2016 5 RESEARCH ARTICLE ISSN: 2278-5213 Growth and Profitability of Selected Cement Industries in India R. Sasikala 1 * and K.P. Balakrishnan 2 1 Dept. of Commerce (CA), Bharathiar

More information

Equity Market Outlook. May, 2016

Equity Market Outlook. May, 2016 Equity Market Outlook May, 2016 Global Economy Update Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 Apr-16 Global Central Bank Monetary Policies

More information

Sun Pharma NEUTRAL. Performance Highlights CMP. 1QFY2013 Result Update Pharmaceutical. `676 Target Price - Investment Period -

Sun Pharma NEUTRAL. Performance Highlights CMP. 1QFY2013 Result Update Pharmaceutical. `676 Target Price - Investment Period - 1QFY2013 Result Update Pharmaceutical August 10, 2012 Sun Pharma Performance Highlights (` cr) 1QFY2013 4QFY2012 % chg qoq 1QFY2012 % chg yoy Net sales 2,658 2,330 14.1 1,636 62.5 Other income (2) 218-110

More information

Investor Presentation

Investor Presentation Investor Presentation www.ajantapharma.com 1 BSE Symbol : AJANTAPH Code: 532331 NSE Symbol : AJANTPHARM ISIN: INE031B01031 Safe Harbour Statement This presentation may include certain forward looking statements,

More information

JUBILANT LIFE SCIENCES Q4 & FY2016 RESULTS

JUBILANT LIFE SCIENCES Q4 & FY2016 RESULTS PRESS RELEASE Noida, Tuesday, May 24, 2016 Jubilant Life Sciences Ltd. 1A, Sector 16A, Noida 201301, India Tel.: +91 120 4361000 http://www.jubl.com JUBILANT LIFE SCIENCES Q4 & FY2016 RESULTS JUBILANT

More information

JUBILANT LIFE SCIENCES Q2/H1 FY2018 RESULTS

JUBILANT LIFE SCIENCES Q2/H1 FY2018 RESULTS PRESS RELEASE Noida, Saturday, Oct 28, 2017 Jubilant Life Sciences Ltd. 1A, Sector 16A, Noida 201301, India Tel.: +91 120 4361000 http://www.jubl.com JUBILANT LIFE SCIENCES Q2/H1 FY2018 RESULTS The Board

More information

Dr Reddy s Laboratories Ltd. Q1 FY05 Financial Performance Review

Dr Reddy s Laboratories Ltd. Q1 FY05 Financial Performance Review Dr Reddy s Laboratories Ltd. NYSE:RDY Financial Performance Review Table of Contents USGAAP Financial Snapshot 02 Revenue Mix 03 Active Pharmaceutical Ingredients 04 Generic Formulations 04 Branded Formulations

More information

Smartness lies in making the right choices. Invest in UTI Opportunities Fund and build your equity portfolio.

Smartness lies in making the right choices. Invest in UTI Opportunities Fund and build your equity portfolio. Smartness lies in making the right choices. Invest in UTI Opportunities Fund and build your equity portfolio. This product is suitable for investors who are seeking*- Long term capital growth Investment

More information

Financial Results Analysis Quarter & 9 Months Ended December 31, 2011

Financial Results Analysis Quarter & 9 Months Ended December 31, 2011 Financial Results Analysis Quarter & 9 Months Ended December 31, 2011 Disclaimer 1 Statements in this document relating to future status, events, or circumstances, including but not limited to statements

More information

Alembic Pharmaceuticals Ltd 25 th September, 2012

Alembic Pharmaceuticals Ltd 25 th September, 2012 Company Report BROKING DEPOSITORY DISTRIBUTION FINANCIAL ADVISORY Alembic Pharmaceuticals Ltd 25 th September, 2012 CMP Target Price Rs.70.85 Rs.90.00 Alembic Pharma continues to maintain its market share

More information

Dec 01, 2016 LAURUS LABS LIMITED. SMC Ranking. (3/5) About the company. Issue Highlights. Strengths. Objects of the Issue. Shareholding Pattern (%)

Dec 01, 2016 LAURUS LABS LIMITED. SMC Ranking. (3/5) About the company. Issue Highlights. Strengths. Objects of the Issue. Shareholding Pattern (%) LAURUS LABS LIMITED Dec 01, 2016 SMC Ranking (3/5) About the company Issue Highlights Industry Pharma Total Issue (Shares) - Offer for sale 24,844,240 Total Issue (Shares) - Fresh Issue 7,009,346 Net Offer

More information

Annual Financial Results. for the twelve months ended 31 December 2009

Annual Financial Results. for the twelve months ended 31 December 2009 Annual Financial Results for the twelve months ended 31 December 2009 1 Introduction and overview Nonkululeko Nyembezi-Heita, CEO 2 Overview (2009 vs 2008) Headline loss of R440m Headline loss per share

More information

Mergers & Acquisitions

Mergers & Acquisitions Mergers & Acquisitions Shailesh Haribhakti 22 nd February, 2014 Overview of global M&A deals Global M&A activity in 2013 was flat (USD 2.22 trillion vs. USD 2.29 trillion in 2012). However H2 was relatively

More information

Lupin Investor Presentation Q3FY14

Lupin Investor Presentation Q3FY14 Lupin Investor Presentation Q3FY14 Vision: To be an innovation led transnational company Safe harbor statement Materials and information provided during this presentation may contain forward looking statements.

More information

GRANULES INDIA LIMITED

GRANULES INDIA LIMITED Independent Equity Research PHARMACEUTICALS BSE Scrip Code: 532482 CMP Rs. 70.35 1 14 Feb 2012 Vertically intergrated and present across the pharma manufacturing value chain Granules India Limited (Granules)

More information

India Economic Factsheet

India Economic Factsheet 1 India Economic Factsheet (As of February 2015) ECONOMIC PROJECTIONS 2013 2014 2015 (F) GDP (Trillion US$) 1.88 2.04 2.16 Real GDP growth 4.47 4.8 5.6 GDP per capita in PPP 5,412 5,777 6,176 Exports (Billion

More information

Steel In The News. A compilation of leading news items on Indian steel industry as reported in major national dailies. Company News 2.

Steel In The News. A compilation of leading news items on Indian steel industry as reported in major national dailies. Company News 2. Steel In The News A compilation of leading news items on Indian steel industry as reported in major national dailies CONTENTS Page Company News 2 Projects 3 Global Steel 3 Financials 4 Prices 5 Steel Market

More information

Alembic Pharmaceuticals Ltd. Investor Presentation

Alembic Pharmaceuticals Ltd. Investor Presentation Alembic Pharmaceuticals Ltd Investor Presentation October-2016 Contents 1. Milestones 2. Quarterly Highlights 3. Half yearly Highlights 4. Business - International - India Branded 5. Strategy 6. Financials

More information

Analyst Meet Presentation Q4 FY10

Analyst Meet Presentation Q4 FY10 Analyst Meet Presentation Q4 FY10 Agenda Economic Scenario Steel Scenario Operating Highlights Project Progress Financial Performance 2 Improving Global Outlook 10 0 10 Centre depicts zero and periphery

More information

REFERENCE NOTE. No. 28/RN/Ref./November /2013

REFERENCE NOTE. No. 28/RN/Ref./November /2013 LOK SABHA SECRETARIAT PARLIAMENT LIBRARY AND REFERENCE, RESEARCH, DOCUMENTATION AND INFORMATION SERVICE (LARRDIS) MEMBERS REFERENCE SERVICE REFERENCE NOTE. No. 28/RN/Ref./November /2013 For the use of

More information

INDIA ENHANCED EQUITY FUND

INDIA ENHANCED EQUITY FUND DSP BlackRock INDIA ENHANCED EQUITY FUND Alternative Investment Fund Quarterly Report uly-september 201 ALTERNATIVE INVESTMENT FUND Investment Commentary We maintained a cautious view on the overall market

More information

Subscribe to Coal India IPO

Subscribe to Coal India IPO Subscribe to Coal India IPO ETHICAL WEALTH CITY INVESTMENT SERVICE PVT LTD, 12/27, MADDOX STREET, CHOOLAI, CHENNAI-112 Page 1 Subscribe to Coal India IPO The biggest ever Initial Public Offer opens today

More information

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart 1QCY2016 Result Update Pharmaceutical May 5, 2016 Sanofi India Performance Highlights Y/E Dec. (` cr) 1QCY2016 4QCY2015 % chg (qoq) 1QCY2015 % chg (yoy) Net sales 506 522 (3.1) 460 10.1 Other income 64

More information

Orient Paper & Industries Ltd

Orient Paper & Industries Ltd GICS Industry : Construction Materials l Sub Industry : Construction Materials l Website : www.orientpaperindia.com Orient Paper & Industries Ltd Key Stock Indicators NSE Ticker : ORIENTPPR Bloomberg Ticker

More information

A study on impact of cost structure on financial performance of selected pharmaceutical companies in India

A study on impact of cost structure on financial performance of selected pharmaceutical companies in India 2016; 2(2): 90-94 ISSN Print: 2394-7500 ISSN Online: 2394-5869 Impact Factor: 5.2 IJAR 2016; 2(2): 90-94 www.allresearchjournal.com Received: 07-12-2015 Accepted: 10-01-2016 Dr. JP Kumar Director, Rathinam

More information

Union Budget Swiss - Indian Chamber of Commerce April, #Budget2018 #KPMGBudgetLive. kpmg.com/in/unionbudget18

Union Budget Swiss - Indian Chamber of Commerce April, #Budget2018 #KPMGBudgetLive. kpmg.com/in/unionbudget18 Union Budget 2018-19 Swiss - Indian Chamber of Commerce April, 2018 #Budget2018 #KPMGBudgetLive kpmg.com/in/unionbudget18 Contents 1 India and the World 2 Overview of Indian Corporation Tax Regime 3 Budget

More information

Economic Reforms. Liberalisation, Privatisation and Globalisation

Economic Reforms. Liberalisation, Privatisation and Globalisation Economic Reforms Liberalisation, Privatisation and Globalisation India s Economic Reform A move away from Inward looking economy to a more open economy or export oriented strategy of growth. That in turn

More information

Aurobindo Pharma BUY. Performance Highlights CMP. `580 Target Price `823. 4QFY2017 Result Update Pharmaceutical. Investment Period 12 months

Aurobindo Pharma BUY. Performance Highlights CMP. `580 Target Price `823. 4QFY2017 Result Update Pharmaceutical. Investment Period 12 months Nov-12 Jun-13 Dec-13 Jul-14 Jan-15 Aug-15 Feb-16 Sep-16 Apr-17 4QFY2017 Result Update Pharmaceutical June 2, 2017 Aurobindo Pharma Performance Highlights Y/E march (` cr) 4QFY17 3QFY17 % chg (QoQ) 4QFY16

More information

Drug Reimbursement - Croatia. Roganovic Jelena

Drug Reimbursement - Croatia. Roganovic Jelena Drug Reimbursement - Croatia Roganovic Jelena Population: 4,292,095 (July 2017) Area: 56,594 km 2 Density: 75.8/km 2 21 counties http://www.lokalniizbori.com/wp-content/uploads/2013/04/hrvatska-%c5%beupanije.jpg;

More information

Aurobindo Pharma BUY. Performance Highlights CMP. `686 Target Price `877. 3QFY2017 Result Update Pharmaceutical. Investment Period 12 months

Aurobindo Pharma BUY. Performance Highlights CMP. `686 Target Price `877. 3QFY2017 Result Update Pharmaceutical. Investment Period 12 months 3QFY2017 Result Update Pharmaceutical February 23, 2017 Aurobindo Pharma Performance Highlights Y/E march (` cr) 3QFY17 2QFY17 % chg (QoQ) 3QFY16 % chg (yoy) Net sales 3,844 3,714 3.5 3,432 12.0 Other

More information

Draft Programme Day 1: 22 July hrs Welcome Address Mr S S Bhogal Chairman, CII Punjab State Council, Managing Partner, Bhogal Exports

Draft Programme Day 1: 22 July hrs Welcome Address Mr S S Bhogal Chairman, CII Punjab State Council, Managing Partner, Bhogal Exports DRIVING MAKE IN INDIA 4 th International Conference & Exposition on Indian Steel Industry: Going Global & Sustainable 22 23 July 2015, CII, NR, : Chandigarh 1100 1800 hrs B2B Exposition Draft Programme

More information

Steel In The News. A compilation of leading news items on Indian steel industry as reported in major national dailies. Highlight of the Week 2

Steel In The News. A compilation of leading news items on Indian steel industry as reported in major national dailies. Highlight of the Week 2 Steel In The News A compilation of leading news items on Indian steel industry as reported in major national dailies CONTENTS Page Highlight of the Week 2 Company News 2 Financial Projects Steel Performance

More information